Citicoline Sodium CAS 33818-15-4 Pharmaceutical Raw Material 98% Purity Supplied by Factories

• Function: Medicine;Food Ingredient;Cosmetics
• Certification: ISO, HACCP, KOSHER, Halal; ISO; Brgs
• Age Group: Adults
• Type: Powder
• Gender: Unisex
• Feature: Medicine;Food Ingredient;Cosmetics
• Model NO.: CAS 33818-15-4
• Packaging: Drum
• Storage Note: Sealed and Stored in a Cool and Dry Place
• Logo Printing: With Logo Printing
• Product Type: Powder
• Transport Package: Drum
• Specification: 1kg/5kg/10kg/25kg
• Trademark: GSH-WORLD
• Origin: China
• Production Capacity: 20000 Kg/Month

Product Description

  Citicoline sodium is composed of ribose, cytosineand choline.
  As an endogenous compound, citicoline sodium is an important mediator for the synthesis of cell membrane phospholipids and an external source for the synthesis of acetylcholine.
  Acetylcholine is an important neurotransmitter that plays a very important role in nucleotide metabolism.

Product details

Model NO.	CDCP01
CAS No.	33818-15-4
Formula	C14h25n4nao11p2
Type	Pharmaceutical Intermediates
Appearance	Powder
Quality	Industrial
Colour	White
Certification	ISO9001/Koshar/Halal/FDA
Storage Condition	Sealed and Stored in a Cool and Dry Place.
Quality Guarantee Period	Two Years
MSDS	Available
COA	Available
Transport Package	1kg/Bag; 25kg/Drum
Specification	98%
Trademark	GSH World
Origin	China
HS Code	2942000000
Production Capacity	20000 Kg/Month

Citicoline sodium(C14H25N4NaO11P2)
CAS	33818-15-4
Appearance	White powder
Assay	≥98.0%
Loss on drying	Not more than 1%
Heavy Metal	Not more than 10ppm
Application	Raw material,medicine
Shelf Life	24months when properly stored.

Citicoline sodium, as a neuroprotective agent, can quickly repair damaged neuron cell membranes, increase cerebral blood flow, promote energy metabolism in the brain, and improve cerebral circulation. The curative effect of the disease is certain, and it is currently the best-selling drug in the clinical treatment of brain diseases.

Citicoline sodium is an activator of brain metabolism, which can promote brain cell respiration, improve brain function, promote recovery, and reduce cerebrovascular resistance. It can not only treat neurological diseases caused by craniocerebral injury and cerebrovascular accident, but also Adjuvant therapy for Kinsen's syndrome and Alzheimer's disease has obvious clinical effects on acute stroke, nerve damage and disturbance of consciousness after surgery, and also improves amblyopia, strabismus, and glaucoma.

The administration routes of citicoline sodium include oral administration, intravenous drip and intramuscular injection. In fact, oral administration can be completely absorbed, so its bioavailability is almost the same as that of intravenous administration. It can be widely distributed in various parts of the body, and it can enter the central nervous system through the blood-brain barrier.